InvestorsHub Logo
Followers 40
Posts 7682
Boards Moderated 1
Alias Born 01/04/2006

Re: None

Monday, 12/17/2012 12:01:52 PM

Monday, December 17, 2012 12:01:52 PM

Post# of 196
trial $5.71
Boston Scientific begins clinical trial of patients implanted with INGEVITY pacing leads (BSX) 5.67 : Co announces first patient has been implanted with co's next generation INGEVITY pacing leads in a clinical trial designed to establish the safety, performance and effectiveness of the leads. In the first half of 2013 the company also expects to begin a separate clinical trial, designed to evaluate INGEVITY leads paired with Ingenio pacemakers for use in an MRI setting, to support FDA regulatory approval for this system combination. The company expects to seek approval for this system combination in other markets as well.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BSX News